Forian (FORA) Cash from Discontinued Operations (2022 - 2023)

Forian (FORA) reported Cash from Discontinued Operations of 32426.0 for Q2 2023, down 145.59% on a YoY basis from 71120.0 in Q2 2022, and down 21.68% quarter-over-quarter from 26649.0 in Q1 2023.

Forian (FORA) Cash from Discontinued Operations (2022 - 2023) Analysis & Trends

Forian has reported Cash from Discontinued Operations for 2 years, with the latest figure at 32426.0 in Q2 2023.

  • For the quarter ending Q2 2023, Cash from Discontinued Operations fell 145.59% year-over-year to 32426.0; the trailing twelve-month figure through Mar 2024 stood at 32426.0 (up 97.08% YoY), and the FY2023 full-year result was 59075.0, up 97.65% from the prior year.
  • Cash from Discontinued Operations for Q2 2023 stood at 32426.0, down from 26649.0 in the prior quarter.
  • The five-year high for Cash from Discontinued Operations was 71120.0 in Q2 2022, with the low at 1426426.0 in Q1 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discontinued Operations (Qtr)
1 Veeva Systems 27.42 Bn 20.11 Bn 662.02 Mn -
2 BrightSpring Health Services 12.49 Bn 11.61 Bn 482.22 Mn -
3 Healthequity 7.54 Bn 7.28 Bn 256.31 Mn -
4 Hinge Health 4.94 Bn 4.63 Bn 154.23 Mn -
5 10x Genomics 3.92 Bn 3.38 Bn 106.18 Mn -
6 Doximity 3.82 Bn 3.08 Bn 125.97 Mn -
7 Waystar Holding 3.67 Bn 3.51 Bn 268.04 Mn -
8 Privia Health 2.75 Bn 2.38 Bn 595.71 Mn -
9 Omnicell 1.85 Bn 1.67 Bn 140.36 Mn -
10 Forian 67.60 Mn 36.65 Mn 2.01 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2023 -32,426.00
Jun 30, 2023 -32,426.00
Mar 31, 2023 -26,649.00
Mar 31, 2023 -26,649.00
Dec 31, 2022 -134,371.00
Dec 31, 2022 -134,371.00
Sep 30, 2022 -1.02 Mn
Sep 30, 2022 -1.02 Mn
Jun 30, 2022 71,120.00
Jun 30, 2022 71,120.00
Mar 31, 2022 -1.43 Mn
Mar 31, 2022 -1.43 Mn